b6
14
4e
8
1d
2d
8
27
8
8
32
19
9
50 Christine Hill-kayser
49 16
19
1
49
2
8
1b
1d
18
89
38
1d
2 29
1d
25
38
Christine Hill-Kayser, M.D.
80Associate Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
7
69
Department: Radiation Oncology
4
1
b
1d
46
Contact information
53
4
3
3
3
2
4
b
1f
53
Christine.Hill@Pennmedicine.upenn.edu
22 University of Pennsylvania
31 Radiation Oncology Administrative Offices
16 2nd Floor West
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
22 University of Pennsylvania
31 Radiation Oncology Administrative Offices
16 2nd Floor West
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
2e
Office: 215-662-7771
32 Fax: 215-349-5445
24
ab
12
32 Fax: 215-349-5445
24
13
Education:
21 7 BA 2c (English Language and Literature) c
2f University of Michigan, 2000.
21 7 MD 15 (Medicine) c
47 School of Medicine, University of Pennsylvania, 2005.
c
3
3
3
3
90
Permanent link21 7 BA 2c (English Language and Literature) c
2f University of Michigan, 2000.
21 7 MD 15 (Medicine) c
47 School of Medicine, University of Pennsylvania, 2005.
c
2 29
21
1e
1d
24
2b
29
27
23
1ef Christine Hill-Kayser, Katherine Camberari, Katherine Okonak, Karen Arnold-Korzeinowski, Michelle Iocolano, Andrew Bauer, Dava Szalda, Lisa Schwartz, James Metz, Sogol Mostoufi-Moab: Design and Implementation of Survivorship Care Plans for Adolescents and Young Adults Diagnosed with Thyroid Malignancies. American Society for Therapeutic Radiation Oncology (ASTRO) 2016 Annual Meeting, Boston, Massachusetts October 2026.
29a Steve Braunstein, John Lucas, Joseph Panoff, Arlene Naranjo, Kathryn Karolczuk, Emily Greengard, Yael Mosse, Wendy Fitzgerald, Katherine Matthay, Meaghan Granger, Michael Hogarty, Meredith Irwin, Fan Zhang, Brian Weiss, Julie Park, Gregory Yanik, Rochelle Bagatell, Steven Dubois, Christine Hill-Kayser: A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531). American Society for Therapeutic Radiation Oncology (ASTRO) 2026 Annual Meeting, Boston, Massachusetts October 2026.
cc Ahmed . . Laack: AEWS1221. American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting, Boston, Massachusetts October 2026.
138 Linkowski L, Iocolano M, Marchesani F, Misher C, Metz JMM: Evaluation of a Halo Effect Following Implementation of Community-Based, Single-Vault Proton Centers. Particle Therapy Cooperative Group Annual Meeting, Normandy, France June 2026.
177 Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ.: Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study. 2 3b Pediatr Blood Cancer. 4, May 2026.
21b Lin M, Chen JJ, Bagatell R, Shaaban SG,Lerman BJ, Shusterman S, Ioakeim-Ioannidou M, Yock TI, Catalano P, Elhalawani H, Dusenbery KE, Vo KT, Huang MS, Friedmann AM, Diller LR, Marcus KJ, MacDonald SM, Terezakis SA, Braunstein SE, Hill-Kayser CE, Haas-Kogan DA, DuBois SG and Liu KX: Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy. Cancers. MDPI, Feb 2026.
10b Haertter A, Goel K, Niculcea J, Li T, Hill-Kayser CE, Plastaras J, LaRiviere MJ, Kim MM: Dosimetric Performance Analysis of Pediatric Based Halcyon™ Volumetric Arc Therapy-Based Lung-Sparing Total Body Irradiation. 40 Technol Cancer Res Treat. Jan-Dec 2026.
10c Parham Alaei, Christine Hill-Kayser: Guidelines for Pediatric Radiotherapy Simulation: A Report from the Children’s Oncology Group Radiation Oncology Discipline. Pediatric Blood & Cancer 2026.
171 Song J, Chavez Perez CG, Baron JA, Hill-Kayser CE, Lustig RA, LaRiviere MJ: Feasibility and Safety of Proton Re-irradiation in Recurrent Pediatric CNS Tumors: A Single-institution Retrospective Study. Particle Therapy Cooperative Group North America 2025 Meeting, Shreveport, Louisiana Nov 2025.
2c
7
1d
1f
Selected Publications
1c8 Lauren Linkowski, Michelle Iocolano, Seiichi Villalona, Sriya Potluri, Christina Bach, Karen Arnold-Korzeniowski, James Metz, Christine Hill-Kayser: Predictors and Equity of Distribution of Educational Materials to Patients Receiving Radiation Therapy for Thoracic Malignancies. American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting, Boston, Massachusetts October 2026.1ef Christine Hill-Kayser, Katherine Camberari, Katherine Okonak, Karen Arnold-Korzeinowski, Michelle Iocolano, Andrew Bauer, Dava Szalda, Lisa Schwartz, James Metz, Sogol Mostoufi-Moab: Design and Implementation of Survivorship Care Plans for Adolescents and Young Adults Diagnosed with Thyroid Malignancies. American Society for Therapeutic Radiation Oncology (ASTRO) 2016 Annual Meeting, Boston, Massachusetts October 2026.
29a Steve Braunstein, John Lucas, Joseph Panoff, Arlene Naranjo, Kathryn Karolczuk, Emily Greengard, Yael Mosse, Wendy Fitzgerald, Katherine Matthay, Meaghan Granger, Michael Hogarty, Meredith Irwin, Fan Zhang, Brian Weiss, Julie Park, Gregory Yanik, Rochelle Bagatell, Steven Dubois, Christine Hill-Kayser: A Phase III Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Lorlatinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (ANBL1531). American Society for Therapeutic Radiation Oncology (ASTRO) 2026 Annual Meeting, Boston, Massachusetts October 2026.
cc Ahmed . . Laack: AEWS1221. American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting, Boston, Massachusetts October 2026.
138 Linkowski L, Iocolano M, Marchesani F, Misher C, Metz JMM: Evaluation of a Halo Effect Following Implementation of Community-Based, Single-Vault Proton Centers. Particle Therapy Cooperative Group Annual Meeting, Normandy, France June 2026.
177 Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ.: Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study. 2 3b Pediatr Blood Cancer. 4, May 2026.
21b Lin M, Chen JJ, Bagatell R, Shaaban SG,Lerman BJ, Shusterman S, Ioakeim-Ioannidou M, Yock TI, Catalano P, Elhalawani H, Dusenbery KE, Vo KT, Huang MS, Friedmann AM, Diller LR, Marcus KJ, MacDonald SM, Terezakis SA, Braunstein SE, Hill-Kayser CE, Haas-Kogan DA, DuBois SG and Liu KX: Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy. Cancers. MDPI, Feb 2026.
10b Haertter A, Goel K, Niculcea J, Li T, Hill-Kayser CE, Plastaras J, LaRiviere MJ, Kim MM: Dosimetric Performance Analysis of Pediatric Based Halcyon™ Volumetric Arc Therapy-Based Lung-Sparing Total Body Irradiation. 40 Technol Cancer Res Treat. Jan-Dec 2026.
10c Parham Alaei, Christine Hill-Kayser: Guidelines for Pediatric Radiotherapy Simulation: A Report from the Children’s Oncology Group Radiation Oncology Discipline. Pediatric Blood & Cancer 2026.
171 Song J, Chavez Perez CG, Baron JA, Hill-Kayser CE, Lustig RA, LaRiviere MJ: Feasibility and Safety of Proton Re-irradiation in Recurrent Pediatric CNS Tumors: A Single-institution Retrospective Study. Particle Therapy Cooperative Group North America 2025 Meeting, Shreveport, Louisiana Nov 2025.
2c